Navigation Links
Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
Date:2/27/2008

ties Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from our Company's expectations and projections. The most significant of such risks and uncertainties include, but are not limited to, our ability, and the ability of King Pharmaceuticals Research and Development, Inc. and other pharmaceutical companies, if any, with whom we may license our Aversion(R) Technology, to obtain necessary regulatory approvals and commercialize products utilizing the Aversion(R) Technology, the ability to avoid infringement of patents, trademarks and other proprietary rights or trade secrets of third parties, and the ability to fulfill the FDA's requirements for approving our product candidates for commercial manufacturing and distribution in the United States, including, without limitation, the adequacy of the results of the clinical studies completed to date and the results of other clinical studies, to support FDA approval of our product candidates, the adequacy of the development program for our product candidates, changes in regulatory requirements, adverse safety findings relating to our product candidates, the risk that the FDA may not agree with our analysis of its clinical studies and may evaluate the results of these studies by different methods or conclude that the results of the studies are not statistically significant, clinically meaningful or that there were human errors in the conduct of the studies or otherwise, the risk that further studies of our product candidates are not positive, and the uncertainties inherent in scientific research, drug development, clinical trials, the regulatory approval process, and commercial supply. You are encouraged to review other important risk factors relating to our operations on our web site at http://www.acur
'/>"/>

SOURCE Acura Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion(R) (Abuse-Deterrent) Technology
2. Acura Pharmaceuticals, Inc. Announces Implementation of Reverse Stock Split and New Trading Symbol: ACPH
3. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
4. Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
9. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
10. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
11. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... DePuy Pinnacle hip lawsuits (( ... the artificial hip system caused recipients to suffer ... in the federal multidistrict litigation underway in U.S. ... the most recent Master Case List issued by ... hip replacement lawsuits are now pending in the ...
(Date:3/3/2015)... With a grant of more than $4.5 ... has been named a national coordinating center by the ... for Health: Improving Community Health Through Innovations in Financing ... health and reduce disparities through innovations in collaboration and ... of the center and up to 10 communities over ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Dallas ... as chairman of the upcoming Dallas Rhinoplasty Symposium, to ... three day symposium, which is attended by plastic surgeons ... provide surgeons with detailed information on current topics, emerging ... revision rhinoplasty surgery . , The symposium will ...
(Date:3/3/2015)... March 03, 2015 Retrofit , ... at America’s leading corporations, today announces the appointment of ... executive positions. CEO Mary Pigatti has recruited ... and employee engagement for the fast-growing company, which was ... watch for 2015. , “Retrofit is thrilled to ...
(Date:3/3/2015)... Celestix Networks, the leading provider ... the global availability of Celestix Cloud Edge Security ... most deployed platform for DirectAccess and remote access ... new release enables organizations to manage the Windows® ... single HTML 5 web interface called Comet 2.0. ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 4Health News:Robert Wood Johnson Foundation Names Georgia Health Policy Center National Center for Bridging for Health Initiative 2Health News:Dr. Rod Rohrich to Chair 32nd Annual Dallas Rhinoplasty Symposium 2Health News:Dr. Rod Rohrich to Chair 32nd Annual Dallas Rhinoplasty Symposium 3Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 2Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 3Health News:Retrofit Signals Growth: Corporate Weight Management Company Announces Talent Acquisitions 4Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 3
... medicine is world renowned. It has supernatural effects on ... such article was recently reported in the November 7 ... the great significance of a Chinese medicinal compound, delisheng, ... method. The research team was led by Dr. Ke-Jun ...
... ID at-risk patients years before clinical diagnosis, scientists say ... An international team of scientists has developed a blood ... impairment will go on to develop Alzheimer,s disease. , ... of effective treatments against Alzheimer,s in the future -- ...
... October 15, 2007 New research presented at ... College of Gastroenterology emphasizes the importance of colorectal ... who have a higher incidence of colorectal cancer ... African-Americans had advanced polyps on the right side ...
... 2007 Post-hoc and other analyses of secondary endpoints ... plc,s (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) ulcerative colitis ... in patients with mild to moderate ulcerative colitis. These ... open-label 12-14 month extension study, are being presented this ...
... Level I and II,Trauma Center accreditation status has been ... 2007 through,September 30, 2008: Regional Resource Trauma Center (Level ... Johnstown -- Conemaugh Memorial Medical Center ... Philadelphia -- Hahnemann University Hospital ...
... TORONTO, Oct. 15 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals ... of cancer therapies, today announced that it held ... Drug Administration (FDA) at,which the FDA concurred with ... its lead drug, Neuradiab, a treatment for newly ...
Cached Medicine News:Health News:A Chinese medicine compound has satisfactory anti-cancer effects on hepatocellular carcinoma 2Health News:Blood Test Might Spot Alzheimer's Early 2Health News:Blood Test Might Spot Alzheimer's Early 3Health News:Racial and ethnic differences in colorectal cancer emphasize importance of screening 2Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 2Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 3Health News:New Analyses of long-term LIALDA (mesalamine) data presented at ACG 4Health News:Pennsylvania Trauma Center Accreditation Status 2Health News:Bradmer provides Phase III Neuradiab trial update and guidance 2Health News:Bradmer provides Phase III Neuradiab trial update and guidance 3
(Date:3/3/2015)... -- This industry report package offers the most up-to-date market data on the ... world and in the top 10 global countries. Along with a global ... countries: Australia , China ... Italy , Japan , Russia ... , United States The reports include ...
(Date:3/3/2015)... , March 3, 2015 /CNW/ - The ... seized a health product being injected at Art Nails Ltd., located ... appeared to be unauthorized as it contained no labelling. All products ... authorized by Health Canada and must have approved labelling. ... had been administered to consumers. Potential risks associated with injecting an ...
(Date:3/3/2015)... , March 3, 2015 ... 356 and 240 patients respectively Publications in ... Journal of Clinical Gastroenterology highlight diagnostic value of ... China and across ... Kea Technologies (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the ...
Breaking Medicine Technology:Global Safety Glass Market to 2019 - Market Size, Top 10 Countries, Trends, and Forecasts 2Advisory - Health product seized from Art Nails in Vancouver 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 3Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 4
... The e.cam single-detector system offers ... unrestricted access for gurneys and ... a clinically versatile open gantry, ... body contouring for SPECT and ...
In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM...
Spring Type with lock. Titanium....
The REVEALRT and REVEALXVI PET/CT scanners combine our fastest PET scanner, the REVEALXL, with multi-slice spiral CT scanners from Siemens Medical Systems....
Medicine Products: